Pembrolizumab in relapsed or refractory Richter syndrome

Author:

Armand Philippe1ORCID,Murawski Niels2,Molin Daniel3,Zain Jasmine4,Eichhorst Barbara5,Gulbas Zafer6,Hawkes Eliza A.7ORCID,Pagel John M.8,Phillips Tycel9ORCID,Ribrag Vincent10ORCID,Svoboda Jakub11,Stathis Anastasios12,Chatterjee Arkendu13,Orlowski Robert13,Marinello Patricia13,Christian Beth14

Affiliation:

1. Dana‐Farber Cancer Institute Boston MA USA

2. Universitäts‐klinikum des Saarlandes Innere Medizin I Homburg Germany

3. Experimental and Clinical Oncology Department of ImmunologyGenetics and Pathology Uppsala University Uppsala Sweden

4. City of Hope Duarte CA USA

5. University of Cologne Cologne Germany

6. Anadolu Medical Center Istanbul Turkey

7. Olivia Newton‐John Cancer Research Institute Austin Health Victoria Australia

8. Swedish Center for Blood Disorders and Stem Cell Transplants Swedish Cancer Institute Seattle WAUSA

9. Rogel Cancer Center Ann Arbor MI USA

10. Institut Gustave Roussy Villejuif France

11. Perelman Center for Advanced Medicine University of Pennsylvania Philadelphia PA USA

12. Oncology Institute of Southern Switzerland Bellinzona Switzerland

13. Merck & Co., Inc Kenilworth NJUSA

14. The James Cancer Hospital and Solove Research Institute Ohio State University Columbus OH USA

Funder

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA

Publisher

Wiley

Subject

Hematology

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3